Vaccines With Live Attenuated Virus May Face Greater Post-Marketing, Manufacturing Requirements
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA advisory committee on May 7 will consider Porcine circovirus 1 found in GlaxoSmithKline's Rotarix as well as "adventitious" material found in two other vaccines.